Neuropeptides and Psychiatric Disorders
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Molecular and Cellular Neuroscience".
Deadline for manuscript submissions: closed (1 October 2020) | Viewed by 3203
Special Issue Editor
Interests: pathologies associated with neuropeptides; pharmacology of depression; treatment-resistant depression; post-traumatic depression; markers for psychiatric diseases
Special Issue Information
Dear Colleagues,
The role of neuropeptides as neuromodulators in the brain is often complementary to classical neurotransmitters’ actions. In this context, neuropeptides have been shown to be involved in the pathophysiology of numerous psychiatric disorders, such as anxiety disorders, mood disorders (depression and bipolar disorder), personality disorders, eating disorders, psychotic disorders (schizophrenia), trauma-related disorders (post-traumatic stress or depression), substance abuse disorders, etc.
Due to the health burden of all these psychiatric pathologies, the further development of neuropeptide receptor agonists and/or antagonists with particular properties (such as the crossing of blood-brain barrier) appears crucial for the treatments and the diagnosis of the disorders. The present Special Issue aims to collect original research studies as well as review and perspective articles that provide future directions and advances for the use of neuropeptide ligands as therapeutic agents able to regulate the central and peripheral physiopathology of such disorders. Therefore, articles or reviews should not be restricted to central actions of neuropeptides but may also concern peripheral regulations that influence brain-related behaviors. We would like this Special Issue to become a major reference for those working in the field of neuropeptides associated pathologies.
Dr. Jean Mazella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Neuropeptide
- Depression
- Anxiety
- Eating disorders
- Post-traumatic depression
- Schizophrenia
- Agonist/antagonist
- Blood–brain barrier
